Evidence map›Paper›PMID 40801996›Full record

ArticleNeurochemical research2025

Electroacupuncture Protects Against Post-stroke Cognitive Impairment by Promoting an IL-33/ST2 Axis-Mediated Microglia M2 Polarization.

Yuhan Zhang, Zhimin Ding, Yamin Wang, Hao Liu, Jing Gao, Huiling Wang, Mingli Wu, Xiaodong Feng, Xin Shen

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuhan ZhangRehabilitation Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Zhimin DingSchool of Rehabilitation Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China.
Yamin WangSchool of Rehabilitation Medicine, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Hao LiuThe First Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Jing GaoRehabilitation Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Huiling WangRehabilitation Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Mingli WuRehabilitation Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Xiaodong FengRehabilitation Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450046, China. fxd0502@163.com.
Xin ShenRehabilitation Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450046, China. shenxin319@163.com.

Funding

the Key Scientific and Technological Research and Promotion Project of Henan Province No.222102310648the Key Scientific and Technological Research and Promotion Project of Henan Province No.232102311210
6 · The paper itself

Abstract

Post-stroke cognitive impairment (PSCI) is a common and debilitating complication of stroke that significantly hinders rehabilitation. Electroacupuncture (EA), which integrates traditional acupuncture with electrical stimulation, has been widely applied in clinical practice and shown remarkable efficacy in treating PSCI. However, its underlying mechanisms remain largely unexplored. The PSCI rat model was established by middle cerebral artery occlusion/reperfusion (MCAO/R). EA treatment commenced 24 h after reperfusion and was administered daily for two weeks. To investigate the role of the Interleukin-33 (IL-33)/Interleukin 1 Receptor-Like 1 (ST2) signaling pathway in EA's therapeutic effects, the ST2 inhibitor Astegolimab (Anti-ST2) was stereotactically injected into the lateral ventricle prior to EA intervention. Neurological function was evaluated using the Zea-Longa neurological deficit score, while emotional and cognitive behaviors were assessed through the open field test (OFT) and novel object recognition (NOR) test. Cerebral infarct volume was quantified using 2,3,5-triphenyltetrazolium chloride (TTC) staining. Protein expression in the striatum was analyzed by Western blotting and immunofluorescence staining, and structural alterations were examined using hematoxylin-eosin (HE) staining. Microglial polarization in the ischemic penumbra was evaluated via double immunofluorescence staining. Serum levels of inflammatory cytokines, including interleukin (IL)-33, IL-10, IL-4, TNF-α, IL-1β, and IL-6, were determined using enzyme-linked immunosorbent assay (ELISA). EA markedly enhanced learning and memory in stroke rats, upregulated IL-33 expression, promoted M2 microglial polarization, and preserved the integrity of brain white matter. However, blockade of the IL-33/ST2 pathway with Anti-ST2 diminished the therapeutic benefits of EA, aggravated white matter injury and cerebral infarct volume, and amplified the inflammatory response. EA facilitates microglial polarization toward the M2 phenotype via the IL-33/ST2 signaling pathway, strengthens the structural integrity of cerebral white matter, and promotes neurological recovery after ischemic stroke.

Indexed as

Cognitive DysfunctionElectroacupunctureInterleukin-1 Receptor-Like 1 ProteinInterleukin-33MicrogliaStrokeAnimalsCell PolarityInfarction, Middle Cerebral ArteryMaleRatsRats, Sprague-DawleyReceptors, Interleukin-1Signal TransductionIl33 protein, ratInterleukin-1 Receptor-Like 1 ProteinInterleukin-33Receptors, Interleukin-1ST2 protein, ratCognitive impairmentElectroacupunctureIL-33/ST2Ischemic strokeMicroglial polarization

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.